Bone marrow failure syndromes Flashcards

1
Q

Diamond blackfan anemia clinical features + lab features

A

Lab =
1) infant with progressive macrocytic anemia + reticulocytopenia
2) high EPO level (ineffective erythropoiesis)
Clinical
- congenital malformations (craniofacial abnormalities, thumb anomalies, cardiac anomalies, hypogonadism, intellectual disability)
- short stature
- predisposition to cancer
- bone marrow lacking RBC precursors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Diamond blackfan anemia pathophysiology

A
  • ribosomopathy (gene mutations affecting ribosome synthesis and processing)
  • ribosome defects reslts in activation of TP53 pathway, which impairs erythropoiesis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Diamond blackfan anemia diagnosis

A

Initial evaluation:
- Measurement of fetal hemoglobin (Hgb F; eg, by Hgb electrophoresis)
- Increased erythrocyte adenosine deaminase (eADA) activity
Confirmatory:
- genetic testing for mutations in genes associated with DBA
- bone marrow biopsy but not done at all centers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Diagnostic features of diamond blackfan anemia

A

1) Onset of anemia at age <1 year
2) Macrocytic anemia with no other significant cytopenias
3) Reticulocytopenia
4) Normal marrow cellularity with a paucity of erythroid precursors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Fanconi anemia mechanism

A

Defect in DNA repair and oxidative stress

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Fanconi anemia gene mutations

A

FANCA
FANCC
FANC-G

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Fanconi anemia clinical features

A
  • pancytopenia
  • short stature
  • microcephaly
  • cafe au lait spots
  • hypoplastic thumbs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Fanconi anemia sequelae

A

MDS
AML
ALL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Fanconi anemia diagnosis

A
  • chromosomal breakage studies using diepoxybutane (DEB) (CONFIRM), confirmed with genetic testing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Fanconi anemia treatment

A
  • steroids
  • danazol
  • transplant w/ low dose TBI conditioning and alkylating agent (cytoxan)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Dyskeratosis congenita mechanism

A
  • telomere maintenance dysfunction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Dyskeratosis congenita mutation

A

DKC1 gene mutation
OR TERC gene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Dyskeratosis congenita inheritance pattern

A

x linked or autosomal dominant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Dyskeratosis congenita clinical features

A
  • dyskeratotic hair, nails
  • leukoplakia
  • reticular rash
  • skin hypertrophy
  • ataxia
  • esophageal strictures
  • squamous cell carcinoma of head neck, GI, or GU tract
  • pulmonary fibrosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Dyskeratosis congenita treatment

A
  • androgens
  • can be role for GCSF or ESA
  • transplant curative (ensure donor is not a silent carrier) w/ non-myeloablative conditioning
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

GATA2 1) lab features 2) monomac clinical features

A
  • monocytopenia
  • b and natural kill cell lymphocytopenia
  • mycobacterial infections
  • HPV leading to multiple warts
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

GATA2 treatment

A

stem cell transplant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

GATA2 sequela

A

MDS, AML

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Diamond blackfan mutations and inheritance

A

RPS19 gene (autosomal dominant)
OR
GATA1 (x-linked)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Diamond blackfan anemia treatment

A

steroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Severe congenital neutropenia pathophys

A
  • misfolded neutrophil elastase, leading to neutrophil arrest at promyelocyte phase
22
Q

Severe congenital neutropenia mutation

23
Q

Severe congenital neutropenia clinical features

A
  • *delayed cord separation at birth
  • recurrent infections
24
Q

Severe congenital neutropenia treatment

A

GCSF
transplant

25
Schwachman-diamond syndrome CBC abnormality
- congenital neutropenia
26
Schwachman-diamond syndrome gene mutation
SBDS gene
27
Schwachman-diamond syndrome clinical features
- *neutropenia only - pancreatic insufficiency - skeletal deformities - cognitive dysfunction - Failure to thrive
28
Schwachman-diamond syndrome treatment
- GCSF - transplant
29
Congenital amegakaryocytic thrombocytopenia mechanism
reduced megakaryocytes from defective response to TPO
30
Congenital amegakaryocytic thrombocytopenia gene mutation
TPO receptor gene - CMPL gene
31
Congenital amegakaryocytic thrombocytopenia treatment
transplant plt transfusions
32
wiskott aldrich clinical features
thrombocytopenia immunodeficiency eczema GI bleeds
33
wiskott aldrich treatment
IVIG for infections splenectomy transplant
34
Germline mutation commonly assocaited with Monosomy 7 MDS in young adult patients
GATA2
35
General clinical features of inherited bone marrow failure syndromes
typically slow symptom onset + longer history/variably low blood counts + developmental or other organ system abnormalities
36
Genes associated with Diamond-Blackfan anemia
RPL - 5, 11,19 RPS - 10, 19
37
Very severe aplastic anemia criteria
ANC <200 *think this is the threshold below which pts are at risk of severe infection and death
38
Basic aplastic anemia algorithm since 1990s
IF <40 years (and typically matched related donor) → IF rapidly available MRD (only 15-30%), proceed directly Allo-HSCT IF unavailable → immune suppression as bridge to allo-HSCT (process can take 6-8 weeks) IF count recovery and no clonal evolution, wean immunosuppressive therapy and observe IF refractory/relapse/MDS develops, haploidental or Unrelated donor SCT
39
What is triple IST for aplastic anemia?
Equine ATG + cyclosporine + eltrombopag
40
Sequelae of bone marrow failure disorders
- all have a high risk of cancer: MDS/AML *Also solid tumors in FA, DC, and SDS - hypersensitivity to radiation and chemo in most as well
41
Fanconi anemia inheritance
- most autosomal recessive
42
Pathway fanconi anemia is related to
BRCA2 BRCA2 gene = FANCD1 gene
43
Subtype of fanconi anemia associated with T-ALL
FANCD1 (Biallelic BRCA2)
44
sequelae of telomere disorders and dyskeratosis congenita
1000x risk of head/neck cancers - also derm and anorectal
45
Diamond blackfan anemia and malignancy association
At risk of lower GI + osteosarcoma
46
SCN bone marrow
neutrophil arrest at promyelocyte stage
47
Cyclic neutropenia clinical features
- mouth ulcers - interval fevrs
48
Severe congenital neutropenia treatment
- GCSF can normalize ANC but at a cost (severe osteopenia, splenomegaly, high risk of progression to MDS/AML) *so need transplant *SCT outcomes much better before MDS/AML
49
congenital amegakaryocytic thrombocytopenia gene mutation
c-MPL (TPO receptor)
50
Schwachman diamond syndrome genetic associations
- biallelic TP53 mutations - del(7q)